{"filings":[{"id":1249318,"accession_number":"0001412408-26-000176","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-06-24T20:05:12+00:00","items":["5.07"],"status":"ready","headline":"Phreesia stockholders elect Indig and Kessler, ratify KPMG, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Chaim Indig elected with 42,920,634 votes for; Jon Kessler with 43,200,247 votes for.","Ratification of KPMG as independent auditor for FY ending Jan 31, 2027: 51,326,138 for, 140,574 against.","Non-binding advisory approval of NEO compensation: 42,476,742 for, 855,584 against.","Annual meeting held June 24, 2026; all proposals passed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":695277,"accession_number":"0001412408-26-000166","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-05-27T20:00:50+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q1 FY2027: Revenue $130.9M (+13% YoY), net income $3.0M; restructuring cuts ~200 positions","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $130.9M (+13% YoY); net income $3.0M vs net loss $3.9M YoY; adjusted EBITDA $30.5M.","Payment solutions revenue up 40% (AccessOne contributed 33%); network solutions up 15%; subscription down 3%.","AHSCs 4,708 (+7% YoY); revenue per AHSC $27,811 (+6% YoY); total managed payments $1.786B.","Post-quarter restructuring eliminated ~100 internal + ~100 contractor roles; savings reflected in FY2027 outlook.","New $275M Capital One revolver maturing 2031 replaced prior Credit and Bridge facilities; AccessOne facility expanded to $300M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":12768,"accession_number":"0001412408-26-000145","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-05-11T20:01:50+00:00","items":["8.01"],"status":"ready","headline":"Phreesia eliminates 220 positions (~110 contractors) in restructuring plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restructuring plan eliminates ~220 positions, half contractor roles, to reduce operating expenses.","Company expects costs to be immaterial and incurred primarily in FY2027.","Annualized run-rate expense savings expected; reflected in FY2027 Adjusted EBITDA outlook from March 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92712,"accession_number":"0001412408-26-000138","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Phreesia subsidiary AccessOne Funding ups receivables facility to $300M, extends to 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 9 increases facility limit from $200M to $300M PNC-led facility.","Scheduled termination date extended from May 4, 2026 to April 30, 2029.","Phreesia added as joint and several co-guarantor under amended performance guaranty.","Concentration limit for lower-rated provider receivables raised from 5% to 15% of aggregate securitization value.","Proceeds from receivables sales used for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92711,"accession_number":"0001412408-26-000084","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-04-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia files 8-K to furnish earnings call transcript; no specific results in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Conference call held March 30, 2026 to discuss Q4 and FY2026 results (fiscal year ended Jan 31, 2026).","SEC EDGAR system delay caused late filing of earnings press release; transcript furnished as Exhibit 99.1.","Replay of call available at ir.phreesia.com for 90 days.","No financial figures (revenue, EPS, guidance) are included in the filing text provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103764,"accession_number":"0001412408-26-000074","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q4 FY2026: GAAP net income positive; revenue up 16% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $127.1M (+16% YoY); FY revenue $480.6M (+14% YoY).","Q4 GAAP net income $1.3M vs loss $6.4M; FY net income $2.3M vs loss $58.5M.","FY Adjusted EBITDA $101.5M (up from $36.8M) and free cash flow $54.4M.","AHSCs 4,658 (+7%); revenue per AHSC $27,279 (+8% YoY).","Appointed Jon Kessler to Board of Directors effective April 6, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":480591000.0,"consensus_period":"2026-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103763,"accession_number":"0001412408-26-000057","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.01","1.02","2.03","7.01","9.01"],"status":"ready","headline":"Phreesia enters $275M revolving credit facility, repays bridge loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New senior secured revolver of up to $275M with Capital One as agent; ~$92.2M drawn at closing.","Proceeds used to repay outstanding bridge loan (364-day $110M term loan from Nov 2025) and terminate it.","Company had already repaid $20M of bridge loan in fiscal Q4 ended Jan 31, 2026.","Replaces existing $50M ABL facility (no outstanding balance) which was also terminated without penalty.","CEO states new facility reduces borrowing costs and enhances long-term financial flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103762,"accession_number":"0001412408-26-000054","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Phreesia appoints Jon Kessler to board; directors Cahill and Weintraub to retire at 2026 meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jon Kessler, former HealthEquity CEO and WageWorks founder, appointed to Phreesia board effective April 6, 2026.","Edward L. Cahill and Michael Weintraub to retire from board at 2026 annual meeting; no disagreement.","Board size adjusted: increased to 9 then decreased to 7 following changes.","Kessler receives initial RSU grant ($40,041) and new hire grant ($185,000) with four-year vesting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103761,"accession_number":"0001412408-26-000042","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K/A","filed_at":"2026-01-28T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Phreesia files AccessOne historical financials; FY24 revenue $49.2M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["AccessOne reported FY2024 net income of $4.9M on $49.2M revenue, vs FY2023 net loss of $2.8M on $47.8M revenue.","AccessOne had $283.8M in total assets as of Dec 31, 2024, including $170.1M in net cardholder receivables.","Phreesia filed unaudited pro forma combined financials reflecting the acquisition and a new Bridge Loan.","The AccessOne acquisition was previously announced and closed on November 12, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120019,"accession_number":"0001412408-25-000121","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q3 FY2026 rev $120.3M (+13% YoY), net income $4.3M, closes AccessOne acquisition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $120.3M (+13% YoY); net income $4.3M vs loss of $14.4M prior year.","Adjusted EBITDA $29.1M vs $9.8M; free cash flow $8.8M vs $1.6M.","AHSCs 4,520 (+7% YoY); revenue per AHSC $26,622 (+6%).","Completed AccessOne acquisition on Nov 12, 2025 for ~$160M cash; funded with cash and $110M bridge loan.","Cash and equivalents $106.4M at Oct 31, 2025, up $22.2M from Jan 31, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":353524000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120018,"accession_number":"0001412408-25-000114","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["1.01","2.01","2.03","9.01"],"status":"ready","headline":"Phreesia completes $163M acquisition of AccessOne, funded with $110M bridge loan","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired AccessOne Parent Holdings for approx. $163M in cash on Nov. 12, 2025, using $107M net from new $110M bridge loan, $50M balance sheet cash, and $6M acquired cash.","Entered 364-day $110M secured bridge credit agreement with Goldman Sachs Bank USA as agent; entire amount funded at closing.","Bridge loan bears SOFR plus applicable margin; duration fees of 0.75%, 1.25%, 1.50% apply if outstanding beyond 90, 180, 270 days; matures Nov. 11, 2026.","Amended existing Capital One ABL credit facility to accommodate the acquisition and bridge loan, deeming them permitted transactions.","Company expects to refinance or replace the bridge loan with a long-term credit facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136580,"accession_number":"0001412408-25-000058","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["1.01","2.02","7.01","9.01"],"status":"ready","headline":"Phreesia acquires AccessOne for $160M; posts first net income positive quarter","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of AccessOne for $160M cash; expands addressable market by ~$6B; expected close in Q3/Q4 FY2026.","Q2 revenue $117.3M (+15% YoY), net income $0.7M (first positive quarter vs $18M loss).","Adjusted EBITDA $22.1M (from $6.5M), free cash flow $9.6M (from $3.7M).","Cash $98.3M; financed via new bridge loan; 92% of AccessOne shareholders signed support agreements.","Evan Roberts named President, Provider Solutions; David Linetsky President, Network Solutions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153776,"accession_number":"0001412408-25-000047","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Phreesia stockholders elect directors, ratify auditor, approve say-on-pay at June 25 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Gillian Munson (47.3M for) and Mark Smith (37.7M for) as Class III directors until 2028.","Ratified KPMG LLP as independent auditor for FY ending Jan 31, 2026 (53.6M for, 13.8K against).","Non-binding advisory vote approved named executive officer compensation (46.7M for, 4.9M against, 2.0M broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153775,"accession_number":"0001412408-25-000036","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q1 revenue $115.9M (+15% YoY), raises FY26 Adj. EBITDA guidance to $85-90M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss narrowed to $3.9M from $19.7M; Adj. EBITDA $20.8M vs $4.1M YoY.","Revenue $115.9M (+15% YoY); AHSCs 4,411 (+9% YoY); revenue per AHSC $26,283 (+6%).","Raised FY26 Adj. EBITDA guidance to $85-90M (prev. $78-88M); maintained revenue guidance $472-482M.","Free cash flow $7.5M vs ($6.2M) YoY; cash $90.9M, no debt on credit facility."],"consensus_eps_estimate":0.0727,"consensus_eps_actual":-0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":115936000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172464,"accession_number":"0001412408-25-000005","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q4 revenue $109.7M (+15% YoY); net loss narrows to $6.4M; positive adjusted EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $109.7M (+15% YoY); net loss $6.4M vs $30.6M; adjusted EBITDA $16.4M vs -$3.5M.","FY2025 revenue $419.8M (+18% YoY); net loss $58.5M vs $136.9M; adjusted EBITDA $36.8M vs -$35.4M.","AHSCs 4,341 (+10% YoY) in Q4; total revenue per AHSC $25,266 (+5% YoY); FY2026 guidance ~4,500 AHSCs and higher revenue per AHSC.","Free cash flow positive: Q4 $9.2M (vs -$10.9M); FY $8.3M (vs -$57.5M); cash $84.2M.","Network solutions revenue up 29% YoY; payment processing fees up 5%; clearinghouse wind-down reduced growth 1%."],"consensus_eps_estimate":0.0006,"consensus_eps_actual":-1.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":419813000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189461,"accession_number":"0001412408-24-000145","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q3 revenue $106.8M (+17% YoY), net loss narrows to $14.4M, guides higher","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $106.8M (+17% YoY), net loss $14.4M vs $31.9M loss prior year.","Adjusted EBITDA $9.8M vs -$6.6M; free cash flow $1.6M vs -$11.6M.","FY2025 revenue guidance narrowed to $418-420M from $416-426M; EBITDA raised to $34-36M.","Introduced FY2026 revenue outlook $472-482M; expects ~4,500 AHSCs for FY2026.","AHSCs 4,237 (+15% YoY); Total revenue per AHSC $25,207 (+1% YoY)."],"consensus_eps_estimate":-0.0641,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":310132000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205966,"accession_number":"0001412408-24-000134","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q2 revenue $102.1M (+19% YoY); positive Free Cash Flow $3.7M; raises FY25 Adj. EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $102.1M (+19% YoY); AHSCs 4,169 (+21% YoY); net loss improved to $18.0M from $36.8M.","Adjusted EBITDA $6.5M vs -$11.5M YoY; Free Cash Flow positive $3.7M vs -$15.2M.","Raised FY25 Adj. EBITDA guidance to $26-$31M (from $21-$26M); revenue outlook unchanged $416-$426M.","Cash $81.8M; no borrowings on credit facility; expects AHSCs ~4,200 for FY25."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":203332000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222982,"accession_number":"0001412408-24-000128","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-06-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Phreesia stockholders elect directors, ratify KPMG, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected three Class II directors: Lisa Egbuonu-Davis, Lainie Goldstein, Ramin Sayar, each with >48.4M votes for.","Ratified KPMG as independent auditor for FY2025: 50.6M votes for, 182k against, 15k abstentions.","Advisory approval of named executive officer compensation: 44.7M for, 4.1M against, 23k abstentions.","All proposals passed as recommended by board; no material changes to governance disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222981,"accession_number":"0001412408-24-000126","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Phreesia appoints Yvonne Hui as VP, Principal Accounting Officer, replacing Janet Gunzburg","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Yvonne Hui appointed VP and Principal Accounting Officer effective June 20, 2024.","Janet Gunzburg ceases as principal accounting officer effective June 19, 2024.","Hui previously served as VP, Revenue Recognition and Billing Operations at Phreesia since March 2022, and prior roles include Google Cloud Controller and Spotify Revenue Accounting Director.","No family relationships or arrangements with other persons regarding Hui's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222980,"accession_number":"0001412408-24-000117","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q1 revenue $101.2M (+21% YoY); lowers FY25 revenue outlook, raises EBITDA outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $101.2M, up 21% YoY; net loss improved to $19.7M from $37.5M.","Adjusted EBITDA positive at $4.1M vs negative $13.8M last year.","FY2025 revenue guidance lowered to $416M-$426M from $424M-$434M due to client wind-down.","FY2025 Adjusted EBITDA guidance raised to $21M-$26M from $12M-$20M.","AHSCs up 23% to 4,065; revenue per AHSC down 2% to $24,900."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":101217000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242470,"accession_number":"0001412408-24-000038","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Phreesia Q4 rev $95M (+24% YoY), Adj EBITDA -$3.5M; forms India sub for in-sourcing","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $95.0M (+24% YoY); full-year revenue $356.3M (+27% YoY).","Q4 net loss $30.6M (vs $38.0M); Adj EBITDA -$3.5M (vs -$17.6M) — strong margin improvement.","FY2025 outlook: revenue $424-434M, Adj EBITDA $12-20M (narrowed upward from $10-20M).","New wholly-owned subsidiary Phreesia India formed to in-source offshore services; expects ~2,400 headcount post-transition.","Cash and equivalents $87.5M, down from $176.7M a year ago; borrowing capacity available."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":356299000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259864,"accession_number":"0001412408-23-000193","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-12-05T23:59:59+00:00","items":["1.01","1.02","2.02","2.03","5.02","9.01"],"status":"ready","headline":"Phreesia reports Q3 revenue $91.6M (+25% YoY), raises FY24 EBITDA outlook, introduces FY25 profitability target","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $91.6M (+25% YoY); net loss $31.9M vs $40.2M; subscription revenue +29%.","Adjusted EBITDA -$6.6M, improved from -$18.3M; FY24 outlook raised to ~$39M (from -$54M to -$49M).","FY25 revenue outlook $424M-$434M; Adjusted EBITDA target $10M-$20M; $500M annualized revenue now expected in FY26.","New $50M 5-year asset-based revolving credit facility with Capital One; replaced SVB; $0.8M termination fees.","SVP Michael Davidoff to leave on Jan 19, 2024 to pursue other opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":261294000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277131,"accession_number":"0001412408-23-000123","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-09-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia reports Q2 FY2024 revenue $85.8M (+26% YoY); raises EBITDA outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $85.8M vs $67.9M YoY (+26%); AHSCs 3,445 (+24% YoY).","Net loss $36.8M vs $46.7M YoY; adjusted EBITDA -$11.5M vs -$26.0M YoY.","Raises FY2024 adj. EBITDA outlook to -$54M to -$49M from -$60M to -$55M; revenue outlook unchanged $353M-$356M.","Acquired MediFind for ~$9M in June and Access eForms for $38.4M in August.","Payment processing revenue $23M (+21% YoY); take rate 2.91%, payment facilitator volume 82%."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":169675000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277130,"accession_number":"0001412408-23-000101","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"Phreesia acquires Access eForms for ~$43M; issues 1.1M shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration for Access eForms ~$43M, partly cash plus 1,096,436 shares of common stock.","Acquisition closed August 11, 2023; share price based on 30-day VWAP as of August 4, 2023.","Also acquired MediFind on June 30, 2023 for ~$9M, issuing 150,786 shares as partial consideration.","Shares issued in both acquisitions rely on Section 4(a)(2) exemption from registration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277129,"accession_number":"0001412408-23-000095","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Phreesia appoints Dr. Lisa Egbuonu-Davis to Board and adopts 2023 Inducement Award Plan","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Dr. Lisa Egbuonu-Davis as Class II director effective July 13, 2023, to serve until 2024 annual meeting.","Received pro-rated annual RSU grant valued at $177,418, vesting on the earlier of one year or next annual meeting.","Received additional new hire RSU grant valued at $185,000 with a four-year graded vesting schedule.","Board adopted 2023 Inducement Award Plan reserving 500,000 shares for grants to new employees and executives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277128,"accession_number":"0001412408-23-000083","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-07-03T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Phreesia registers shares for resale by selling stockholders, files legal opinion","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Filed prospectus supplement for resale of common stock by certain selling stockholders.","Lowenstein Sandler LLP opines on legality of registered shares.","No new shares issued; registration covers existing shares held by selling stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295030,"accession_number":"0001412408-23-000081","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Phreesia stockholders elect all three Class I directors; all four proposals pass at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Chaim Indig, Michael Weintraub, Edward Cahill elected as Class I directors; Indig 45.3M votes for, Weintraub 32.4M, Cahill 28.2M.","Ratification of KPMG as auditor approved: 48.7M for, 6,243 against.","Non-binding say-on-pay passed: 42.3M for, 3.7M against.","Amendment to limit officer liability under Delaware law approved: 41.1M for, 4.9M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295029,"accession_number":"0001412408-23-000073","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q1 revenue $83.8M (+32% YoY); net loss narrows, FY24 EBITDA outlook raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $83.8M, up 32% YoY; net loss $37.5M vs $51.2M in prior-year quarter.","Adjusted EBITDA -$13.8M (improved from -$30.6M); FY24 outlook raised to -$60M to -$55M.","AHSCs 3,309 (+31% YoY); Network Solutions revenue +46% driven by Life Sciences campaigns.","SVB consent extended to Sep 15, 2023; cash reserves $149.8M sufficient for 12+ months."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":83845000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295028,"accession_number":"0001412408-23-000074","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K/A","filed_at":"2023-05-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Phreesia sets compensation for PAO: $275k salary, $110k bonus target","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary $275,000 per year; target annual bonus $110,000; effective March 24, 2023.","Non-CIC severance: 6 months salary, prorated bonus, 6-month equity vesting acceleration, up to 6 months COBRA.","Change-in-control: 50% of time-based equity accelerates; remaining vests on first anniversary.","Post-CIC termination within 12 months: full equity acceleration, 1x base+target severance, prorated bonus, 12 months COBRA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":315588,"accession_number":"0001412408-23-000017","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-03-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q4 FY2023 revenue $76.6M (+32% YoY); FY2024 guidance revenue $353-356M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $76.6M (+32% YoY); net loss $38.0M vs $46.5M loss year ago; Adj. EBITDA -$17.6M vs -$30.5M.","AHSCs 3,140 (+36% YoY); Healthcare services revenue per AHSC $17,705 (-4% YoY).","Full year revenue $280.9M (+32%); net loss $176.1M vs $118.2M prior year; Adj. EBITDA -$92.5M.","FY2024 outlook: revenue $353-356M (26-27% growth); Adj. EBITDA loss -$65M to -$60M (improvement).","Cash $176.7M at Jan 31; transferred funds from SVB on March 9 before FDIC receivership; all cash available."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":280910000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":315587,"accession_number":"0001412408-23-000016","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2023-03-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Phreesia appoints Balaji Gandhi as CFO; Randy Rasmussen steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Balaji Gandhi appointed CFO effective March 24, 2023, succeeding Randy Rasmussen.","Rasmussen will serve as strategic advisor to facilitate transition.","Gandhi previously SVP Investor Relations at Phreesia, joined in 2019 pre-IPO.","Employment agreement: base salary $400k, target bonus $300k, severance provisions.","Janet Gunzburg appointed Principal Accounting Officer, effective March 24."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":333931,"accession_number":"0001412408-22-000066","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2022-12-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q3 revenue $73.1M (+31% YoY); raises FY2023 outlook to at least $278M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $73.1M (+31% YoY); net loss $40.2M; Adjusted EBITDA -$18.3M.","Average healthcare services clients 2,982 (+42% YoY); ARPU $17,645 (-9% YoY).","Raises FY2023 revenue outlook to at least $278M; Adjusted EBITDA outlook improved to ~$95M.","Renames 'Life sciences' revenue to 'Network solutions'; introduces MemberConnect for payers.","Estimated TAM expanded to ~$10B from ~$9B due to MemberConnect opportunity."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":204324000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":351371,"accession_number":"0001412408-22-000049","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2022-09-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q2 FY2023 revenue $67.9M (+33% YoY); raises FY revenue and EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $67.9M, up 33% YoY; average healthcare clients 2,776 (+40% YoY).","Adjusted EBITDA loss widened to $26.0M from $11.0M in prior year.","FY2023 revenue guidance raised to $273M-$275M; Adj. EBITDA guidance improved to negative $106M-$109M.","Cash $240.7M, down $73.1M from Jan; expects $165M-$170M by Jan 31, 2023.","Average revenue per healthcare client $18,248, down 7% YoY as client growth outpaced payment volume."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":131221000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368717,"accession_number":"0001412408-22-000043","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2022-06-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Phreesia shareholders elect two Class III directors, ratify KPMG, approve exec compensation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gillian Munson and Mark Smith elected Class III directors with 33.3M and 33.1M votes for.","KPMG LLP ratified as independent auditor for FY ending Jan 31, 2023 with 46.5M votes for.","Non-binding advisory vote approved executive compensation: 42.6M for, 2.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368716,"accession_number":"0001412408-22-000034","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2022-06-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q1 revenue $63.4M (+31% YoY); FY23 Adj. EBITDA guidance raised to -$126M to -$122M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $63.4M vs $48.3M YoY; client count 2,526 (+33% YoY); avg. rev. per client $19,193 (-5% YoY).","Adjusted EBITDA -$30.6M vs +$0.1M YoY; cash $269.2M, down $44.6M from Jan 2022.","FY23 revenue outlook maintained $271M-$275M; Adj. EBITDA outlook raised to -$126M to -$122M from -$154M to -$149M.","Company expects FY23 Adj. EBITDA to be low mark for FY23-FY25, targeting profitability in FY2025.","Life sciences revenue $16.3M; patient payment volume $837M (+19% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":63354000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":387966,"accession_number":"0001412408-22-000013","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2022-03-30T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"Phreesia upsizes credit line to $100M; Q4 revenue up 39% but EBITDA plunges, FY23 guidance weak","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $58.0M (+39% YoY); FY2022 revenue $213.2M (+43% YoY).","Q4 Adjusted EBITDA -$30.5M (vs -$0.1M); FY2022 Adj. EBITDA -$59.0M (vs +$3.8M).","FY2023 revenue guidance $271M–$275M (27–29% growth); Adj. EBITDA guidance -$154M to -$149M.","New $100M revolving credit facility with SVB, upsized from $50M; floating rate (prime –0.50%, floor 3.25%).","Cash and equivalents $313.8M at Jan 31, 2022, up from $218.8M a year ago; quarterly burn increased."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":213233000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":405898,"accession_number":"0001412408-21-000090","cik":1412408,"company_name":"Phreesia, Inc.","ticker":"PHR","form_type":"8-K","filed_at":"2021-12-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Phreesia Q3 revenue $55.9M (+45% YoY); FY22 outlook raised to $211M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $55.9M, up 45% YoY; net loss $36.3M ($0.71/share) vs $6.7M loss prior year.","Adjusted EBITDA -$17.6M vs +$1.2M a year ago, reflecting increased growth investment.","FY2022 revenue outlook raised to $211M from $195-198M; FY2023 growth guided 20-25%.","Cash $400.4M after follow-on offering generating $245.8M net proceeds.","Agreed to acquire Insignia Health for $35M cash; adds Patient Activation Measure (PAM)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":155213000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":589944459.3537788,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}